Login / Signup

Short-acting β 2 -agonist use and asthma exacerbations in Swedish children: A SABINA Junior study.

Erik MelénBright Ibeabughichi NwaruFredrik WiklundSofie de Fine LichtGunilla TelgEkaterina MaslovaRalf J P van der ValkTrung N TranMagnus EkströmChrister Janson
Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2022)
High SABA use was associated with increased asthma exacerbation risk in children, particularly in those without comorbid atopic diseases, emphasizing the need for asthma medication reviews and reformative initiatives by caregivers and healthcare providers on SABA use.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • healthcare
  • young adults
  • allergic rhinitis
  • cystic fibrosis
  • randomized controlled trial
  • air pollution
  • intensive care unit
  • adverse drug